Ignite Creation Date:
2024-05-06 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03522246
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2018-04-09
Brief Title:
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Sponsor:
pharmaand GmbH
Organization:
pharmaand GmbH
Organization Data
Organization:
pharmaand GmbH
Class:
INDUSTRY
Study ID:
CO-338-087GOG-3020ENGOT-ov45
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
pharmaand GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Foundation Medicine | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |
| Gynecologic Oncology Group | NETWORK |
| European Network of Gynaecological Oncological Trial Groups ENGOT | OTHER |